Arogga is a technology company.
Arogga has raised $1.0M across 1 funding round.
Arogga has raised $1.0M in total across 1 funding round.
Arogga has raised $1.0M in total across 1 funding round.
Arogga's investors include Company Capital, Frontier Ventures, Hyper, LearnStart, Smash Capital, Vibe Capital, George Burke.
Arogga is a Bangladesh-based healthtech startup founded in December 2020 that operates as the country's first mega online pharmacy, delivering a comprehensive health solutions platform via its mobile app.[1][2][3] The app enables users to upload prescriptions for quick medicine delivery, offers over 32,000 genuine medicines and healthcare products from 500+ manufacturers—including vitamins, supplements, pain relievers, and beauty care items—and serves more than 600,000 users primarily in Dhaka with plans for expansion.[1][2] It tackles healthcare access challenges in Bangladesh by providing convenient, affordable medicine delivery, user-friendly search with detailed product info, price comparisons, rewards (up to 10% savings and referral cash), and chat support, while evolving into a super app with lab testing and doctor consultations.[1][2][3]
Arogga solves problems like counterfeit drugs, limited pharmacy access, and high costs through in-house logistics, technology-driven operations, and a focus on trust-building, achieving strong growth with a $5.5 million seed round in 2023 (including $4 million new capital) after an earlier $1.3 million raise.[1][3] With 51-200 employees and headquarters in Dhaka, it prioritizes penetration in major cities like Dhaka and two others by Q2 2024, alongside launching home lab testing.[1][3]
Arogga was founded in December 2020 by Rosina Mazumder (CEO), Fahad Hossain (COO), Shamim Hasan (CTO), and Yawar Mehboob (CFO), who identified gaps in Bangladesh's healthcare delivery amid challenges like limited access and counterfeit medicines.[1][2] The idea emerged to bring a "healthcare system to your doorstep" via an app allowing prescription uploads for fast, safe delivery, starting as an online pharmacy and quickly scaling to a full platform.[2] Early traction came from offering a wide product range and features like easy search and comparisons, building to 600,000+ users; a pivotal $1.3 million seed round fueled nationwide delivery, followed by the landmark $5.5 million raise in 2023 to expand services.[1][3]
Arogga rides the healthtech digitization wave in emerging markets like Bangladesh, where rising smartphone penetration (over 50% urban) meets chronic issues like pharmacy scarcity, counterfeit drugs (up to 30% of market per regional reports), and urban congestion limiting physical access.[1][2][3] Timing aligns with post-COVID demand for contactless healthcare and government pushes for digital services, amplified by investor interest in Southeast Asian healthtech (e.g., seed rounds surging 2023).[1][3] Market forces favoring Arogga include a young population (median age ~28), growing e-pharmacy adoption, and untapped rural expansion; it influences the ecosystem by setting standards for genuine delivery, inspiring competitors, and partnering for logistics/tech to normalize super apps in underserved regions.[1]
Arogga is poised to dominate Bangladesh's e-pharmacy market through 2026, leveraging its $5.5 million seed for Q2 2024 city expansions, lab testing launches, and super app features like consultations amid projected 20-30% annual healthtech growth in South Asia.[1] Trends like AI-driven personalization, regional cross-border logistics, and insurance integrations will shape its path, potentially enabling Southeast Asian entry. Its influence may evolve from local disruptor to regional health gateway, building on trust and operations to capture a $1B+ market—reinforcing its mission to make healthcare accessible at a click.[1][2]
Arogga has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $1.0M Seed | Company Capital, Frontier Ventures, Hyper, LearnStart, Smash Capital, Vibe Capital, George Burke |